Click the above logo to link to the Gardasil website

CSL Biotherapies is a global, specialty biopharmaceutical company that develops, manufactures and markets products to treat and prevent serious human medical conditions.  Innovation and new product development for unmet medical needs continue to drive CSL Biotherapies growth.

Headquartered in Melbourne Australia, the CSL Group includes CSL Biotherapies, CSL Bioplasma and CSL Behring incorporating ZLB Plasma Services.  With major facilites in Australia, Germany, Switzerland, US and Japan, CSL has over 9000 employees working in more than 27 countries.